Peter R. Paradiso - Publications, H-index & Citations

Peter R. Paradiso

Pfizer

29H指数

80论文数

4.9K被引数

收录论文 10

发表时间

Adult indication 13-valent pneumococcal conjugate vaccine clinical development overview: formulation, safety, immunogenicity (dosing and sequence), coadministration, and efficacy

EXPERT REVIEW OF VACCINES

IF4.8

2024-09-25

OAAI

Fletcher, Mark A.; Schmoele-Thoma, Beate; Vojicic, Jelena; Daigle, Derek; Paradiso, Peter R.; Morales, Graciela del Carmen

Reassessing the 1+1 pneumococcal conjugate vaccine schedule

LANCET INFECTIOUS DISEASES

IF31

2018-04-01

OAAI

Isturiz, Raul; Gessner, Bradford D.; Madhava, Harish; Paradiso, Peter; Jodar, Luis

Pneumococcal conjugate vaccine use in adults 肺炎球菌结合疫苗在成人中的应用

EXPERT REVIEW OF VACCINES

IF4.8

2015-12-29

PREAI

Isturiz, Raul E.; Schmoele-Thoma, Beate; Scott, Daniel A.; Jodar, Luis; Webber, Chris; Sings, Heather L.; Paradiso, Peter

Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged ≥50 Years With Community-Acquired Pneumonia 13价肺炎球菌结合疫苗肺炎链球菌血清型在 ≥ 50岁社区获得性肺炎的美国成年人中的分布

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2013-10-02

PREAI

Sherwin, Robert L.; Gray, Sharon; Alexander, Ronika; McGovern, Paul C.; Graepel, Jay; Pride, Michael W.; Purdy, Jay; Paradiso, Peter; File, Thomas M., Jr.

Expression of adhesion molecules and extracellular matrix proteins in glioblastomas: Relation to angiogenesis and spread 胶质母细胞瘤中粘附分子和细胞外基质蛋白的表达: 与血管生成和扩散的关系

HISTOPATHOLOGY

IF4.1

2003-10-30

PREAI

Vitolo, D; Paradiso, P; Uccini, S; Ruco, LP; Baroni, CD

Geographical differences for pneumococcal disease - Reply

LANCET

IF88.5

2001-08-01

PREAI

Hausdorff, WP; Siber, G; Paradiso, PR

Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children

LANCET

IF88.5

2001-03-01

198

PREAI

Hausdorff, WP; Siber, G; Paradiso, PR

The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use, part II

CLINICAL INFECTIOUS DISEASES

IF7.3

2000-01-01

292

OAAI

Hausdorff, WP; Bryant, J; Kloek, C; Paradiso, PR; Siber, GR

Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I

CLINICAL INFECTIOUS DISEASES

IF7.3

2000-01-01

717

PREAI

Hausdorff, WP; Bryant, J; Paradiso, PR; Siber, GR

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants

PEDIATRICS

IF6.4

1998-04-01

352

PREAI

Rennels, MB; Edwards, KM; Keyserling, HL; Reisinger, KS; Hogerman, DA; Madore, DV; Chang, I; Paradiso, PR; Malinoski, FJ; Kimura, A

研究方向